Royalty Report: Delivery, Medical, Drugs – Collection: 282943

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Delivery
  • Medical
  • Drugs
  • Supply

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 282943

License Grant
The Netherlands Licensee hereby grants to Licensor, and Licensor hereby accepts, the right of first refusal to be granted a license under all future patents and patent applications in connection with the PolyActive Technology for the non-exclusive use by Licensor of the PolyActive Technology in the Orthopedic Field and/or for use as a medical device not containing a biological active agent(s). Such right will be subject to a royalty.

Licensee grants to Licensor and Licensor accepts, as from the Effective Date, an exclusive, unlimited, world-wide, perpetual, royalty-free license, with the right to grant sub-licenses to make, use, sell, market and develop any PolyActive Rights B relating to osseouschondral and/or osteochondral plugs, fillers, cement restrictors, or the like, including but not limited to SynPlug(TM) (Licensee License B.)

Licensee grants to Licensor and Licensor accepts, as from the Effective Date, an exclusive, unlimited, world-wide, perpetual, royalty-free license, with the right to grant sub-licenses to make, use, sell, market and develop any PolyActive Rights A and/or PolyActive Rights B related to the use of the PolyActive Technology in a medical device to be used to measure and/or monitor blood glucose (Licensor License AB).

License Property
PolyActive Technology shall mean a drug delivery system controlling the release of biologically active molecules, which is based on PolyActive. Products based on PolyActive Technology can be used for both local and systemic administration, and have applications in pharmaceutics and medical technology.

PolyActive shall mean a biodegradable (amphiphilic) poly(ether-ester) multiblock copolymer based on PEGT and PBT.

CHIENNA-Patents shall mean the patents and patent applications defined and listed in Annex I(A) to the ACLA.

PolyActive Rights A shall mean the PolyActive Rights A as defined and listed in Annex 3.2, consisting of the CHIENNA-Patents but not including all previously abandoned and/or transferred patents and patent applications.

6,685,957 – Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique
5,980,948 – Polyetherester copolymers as drug delivery matrices

PolyActive Rights B Shall mean the PolyActive Rights B as defined and listed in Annex 3.1, consisting of the Licensor-Patents but not including (1) all previously abandoned and/or transferred patents and patent applications; (2) the Osteoinduction patent family; and (3) the Cement Restrictor 4th Design.

6,479,418 – Porous ceramic body
6,069,295 – Implant material

Field of Use
PolyActive is a biodegradable polymeric drug delivery system.  Licensee uses PolyActive to develop its controlled-release alfa interferon product LocteronTM.

Locteron is a controlled release formulation of interferon alfa for the treatment of chronic hepatitis C, currently in Phase IIa studies.

Orthopedic Field shall mean that part of the Licensees patents and patent application which relate to a therapeutic application to the musculoskeletal system, including bone, cartilage, joints, related connective tissues, ligaments, tendons and nerves.

PolyActive technology and its intellectual property in certain strategic areas, including additional applications in orthopedics.

IPSCIO Record ID: 27367

License Grant
Licensor of Netherland hereby grants to Licensee of Netherland an exclusive license for the under Patents and Technology to make, have made, use, import, sell, offer to sell or have sold on its behalf product, including the right to sublicense third parties.
License Property
The Company has exclusively licensed its PolyActive polymer biomaterial technology and patents to Matrix; non-allograft bone tissue.

Tissue Adhesion (Barrier); Method for preventing tissue adhesion 08/279,811 5,480,436 525400-99 USA
Tissue Adhesion (Barrier); Method for preventing tissue adhesion 08/078,350 5,508,306 525400-84 USA
Artificial Skin 574654 5,147,401 525400-151 USA
Substrate for treating skin defect (Second PolyActive artificial skin) 08/298,411 Pending 525400-112 USA
Prosthetic Devices formed from materials having bone-bonding properties and uses 08/389,303 Pending 525400-126 USA therefor. Devices of method?
Prosthetic Devices formed from materials having bone-bonding properties and uses 08/089,857 Pending 525400-68 USA therefor. Devices of method?
Polyester ester copolymers as drug delivery matrices 08/699,896 Pending 525400-157 USA

IPSCIO Record ID: 294272

License Grant
The University grants an exclusive, world-wide license to make, have made, use, import, offer for sale and sell Licensed Products in the Field .
License Property
The University has intellectual property relating to surgically implantable drug delivery systems.

The patents include Polymer-based Surgically Implantable Haloperidol Delivery Systems and Methods for Their Production and Use, and, Drug Containing Implants and Methods of Use Thereof.

M2281    Polymer-based Surgically Implantable Haloperidol Delivery Systems and Methods for Their Production and Use  60/242,304

Q3399-PCT    Long-Term Delivery Formulations and Methods of Use Thereof  US05/00884

S4072    Drug-Containing Implants and Methods od Use Thereof  11/183,232

S4084    Drug containing Implants and Methods of Use Thereof  11/195,845

S4236    Ropinerol Implants for the Treatment of Parkinson’s Disease  S No. 60/789,961

Field of Use
The license from University patent applications and other intellectual property related to the LAD technology to develop and commercialize licensed products

LAD to improve the control, consistency and convenience of medication delivery. LAD is comprised of a biodegradable polymer matrix using commonly available medical polymers and an active drug. It is formed into a small implant for injection just below the skin. We designed LAD to improve the control, consistency and convenience of medication delivery.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.